Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism

Background and aim: Conventional hepatitis C treatment using pegylated interferon (PEG-IFN) and ribavirin is associated with significant side effects. IL28B polymorphism can predict response to treatment, with CC genotype having a better response. ITPA gene deficiency protects against clinically sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekstrom, Victoria, Kumar, Rajneesh, Zhao, Yi, Yee, Mei Ling, Sung, Cynthia, Toh, Dorothy, Loh, Poh Yen, Tan, Jessica, Teo, Eng Kiong, Chow, Wan Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554392/
https://www.ncbi.nlm.nih.gov/pubmed/28852525
http://dx.doi.org/10.1093/gastro/gow033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554392/
https://www.ncbi.nlm.nih.gov/pubmed/28852525
http://dx.doi.org/10.1093/gastro/gow033

Ejemplares similares